TURKISH JOURNAL OF MEDICAL SCIENCES, vol.49, no.5, pp.1358-1365, 2019 (SCI-Expanded)
Article / Article
TURKISH JOURNAL OF MEDICAL SCIENCES
Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
Acute coronary syndrome, atrial fibrillation, ticagrelor, P-WAVE DISPERSION, PULMONARY VEIN ISOLATION, MYOCARDIAL-INFARCTION, ENDOGENOUS ADENOSINE, EUROPEAN-SOCIETY, CARDIOPROTECTION, ELEVATION, THERAPY, HEART, ONSET
Eskisehir Osmangazi University Affiliated:
Background/aim: Ticagrelor is a drug widely used in patients with acute coronary syndromes (ACS) that specifically increases the plasma level of adenosine, which is likely to cause atrial fibrillation (AF). Therefore, in this study we aimed to investigate the electrocardiographic and echocardiographic predictors of AF development after P2Y12 receptor antagonists in ACS patients.